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Abstract
Background: If people with progressive neurological diseases are to avail of evidence-based rehabilitation,
programs found effective in randomized controlled trials (RCT’s) must firstly be adapted and tested in clinical
effectiveness studies as a means of strengthening their evidence base. This paper describes the protocol for
an effectiveness-implementation trial that will assess the clinical effectiveness of a highly challenging balance
training program (the HiBalance program) for people with mild-moderate Parkinson’s disease (PD) while
simultaneously collecting data concerning the way in which the program is implemented. The HiBalance
program is systemically designed to target balance impairments in PD and has been shown effective at
improving balance control and gait in a previous RCT. Study aims are to i) determine the effectiveness of the
adapted HiBalance program on performance and self-rated outcomes such as balance control, gait and
physical activity level ii) conduct a process evaluation of program implementation at the various clinics iii)
determine barriers and facilitators to program implementation in these settings.
Methods: This effectiveness-implementation type 1 hybrid study will use a non-randomized controlled design
with consecutive inclusion of people with PD at multiple clinical sites. A mixed method approach will be
used to collect clinical effectiveness data and process evaluation data which is both quantitative and
qualitative in nature. The consolidated framework for implementation research (CFIR) will be used to guide
the planning and collection of data concerning implementation barriers and facilitators. The HiBalance
program will be provided by physical therapists as a part of standard rehabilitation care at the clinical sites,
while the evaluation of the implementation process will be performed by the research group and funded by
research grants.
Discussion: An effectiveness-implementation study design benefits patients by speeding up the process of
translating findings from research settings to routine health care. Findings from this study will also be highly
relevant for those working with neurological rehabilitation when faced with decisions concerning the
translation of training programs from efficacy studies to everyday clinical practice.
Trial registration: ClinicalTrials.gov march 2016, NCT02727478.
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Background
People with Parkinson’s disease (PD) experience impair-
ments in balance and gait function, symptoms which
can have far-reaching negative effects on their health
and quality of life [1–3]. Injurious falls and fear of falling
are especially prevalent among those with PD [4, 5], a
factor which may partly explain why this group are less
physically active than older people of a similar age with-
out the diagnosis [6–8]. Impairments in balance control
often present in the early stage of the disease and grad-
ually deteriorate in line with disease progression.
Additionally, whereas dopaminergic drugs, the primary
treatment method for PD-related motor symptoms, posi-
tively affect symptoms such as bradykinesia and tremor,
these drugs are also reported to negatively affect compo-
nents of balance control [9]. Both these factors com-
bined highlight the urgency to develop and implement
effective training methods to tackle balance and gait im-
pairments for this patient group.
There is a growing evidence base for the feasibility and
effectiveness of balance training in PD with regards to
various aspects of physical function [10–12]. However,
previous interventions have been criticized for applying
training stimuli which lacked intensity and challenge
[11, 13]. Group-based programs also appear to offer
added motivational advantages for people with PD [12,
14], many of whom experience non-motor symptoms
such as apathy and depression as a feature of the disease
[15]. The HiBalance program [16] was developed with
these considerations in mind to specifically address PD-
specific balance impairments. This group-based program
is highly challenging, progressive and has been proven
effective in improving balance and gait impairments in a
randomized controlled hospital setting [17]. For an
intervention to be considered evidence-based however, it
must be proven effective in both research and clinical
settings [18].
From randomized trial to routine care
It is recognized that efficacious interventions frequently
require adaptation prior to adoption in clinical settings
[19]. This adaptation to clinical factors is often required
to ensure feasibility of the intervention the clinical con-
text [20]. Best practice then involves evaluating the
effectiveness of the adapted program, in order to verify
whether or not the adaptation has attenuated the effect-
ive core elements of the program itself [21]. The major-
ity of research trials however do not reach this phase as
studies among American and European populations sug-
gest that 30 − 40% of patients do not receive care which
is in line with the current best scientific evidence [21,
22]. Similarly, in the field of neurological rehabilitation
for PD, although there are a growing number of pro-
grams tested in randomized controlled environments,
the evidence is lacking as to whether the effects of these
program can be maintained in real life clinical settings.
Clinical effectiveness research is characterised by the
inclusion of more heterogeneous patient samples and
settings which, in turn, places greater emphasis on exter-
nal validity and generalizability of the intervention in
question [23, 24]. In this way, effectiveness studies can
be considered essential links between scientific evidence
and evidence-based practice. There is also empirical evi-
dence to show that the process of implementation is an
important determinant of program outcomes [19]. For
this reason, evaluating the implementation process pro-
vides information regarding the feasibility of interven-
tion programs within real life settings while also
providing important contextual information which may
help explain the success, or lack thereof, of the tested
intervention. When the aim is to maximise the uptake of
interventions in primary care, researchers are also
advised to examine the influence of contextual factors
on implementation, as this will give an indication of the
‘fit’ between the intervention and the context within
which it is being embedded [25].
Rationale for trial design
The effectiveness-implementation hybrid design [26] en-
ables the simultaneous evaluation of both effectiveness
outcome measures as well as of the process of imple-
mentation. This design is therefore hypothesized to
speed up the implementation process of interventions
within healthcare [26]. The type 1 Hybrid design is suit-
able when a study aims to both test effectiveness of a
clinical intervention (outcome evaluation) while simul-
taneously gathering contextual data regarding potential
barriers and facilitators to clinical implementation. Use
of the hybrid design allows for constant monitoring of
the process by which the intervention is applied, and
therefore allow problems in early application to be iden-
tified and quickly altered so as to ensure better out-
comes [19]. Non-randomization in the current study is a
design trade-off which was made in order to ensure that
implementation of the program is practically feasible at
the various clinical sites within a reasonable time-frame.
Lastly, we will adhere to a participatory approach
whereby ‘users’ of the program (physical therapist
trainers) will be actively involved in all stages of the pro-
gram adaptation, process and outcome evaluation. This
approach is recommended in order to increase the rele-
vance, acceptability and successful implementation of
the program [21].
Study aims
This study has three main aims which involve testing
the effectiveness of the HiBalance program:
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Aim I: to test the effectiveness of the adapted balance
training program on balance, gait and physical activity
in people with PD in real-life clinical settings.
Aim II: to conduct a process evaluation of the
effectiveness-implementation study by gathering infor-
mation on the implementation process at the various
clinical settings.
Aim III: to determine barriers and facilitators that
affect implementation of the program in these settings.
The study results will test the hypothesis that the effect-
iveness of the HiBalance program can be retained follow-
ing adaptation of the intervention and study results
should inform future translation of evidence-based train-
ing programs in clinical settings among people with PD.
Methods
Description of the HiBalance program
The intervention involves a 10-week highly challenging
and progressive balance training program in group format
and has been previously described [16]. The group-
training exercises are not fixed but selected to target four
major components of balance control which are known to
be impaired among people with PD; (i) Sensory integra-
tion; (ii) Anticipatory postural adjustments; (iii) Motor
agility and (iv) Stability limits. Trainers are responsible for
the planning, selection and adaption of the exercises as
well as ensuring that exercises are adapted to participants’
individual capacity. Successive progression of exercise dif-
ficulty is achieved by dividing the 10-week period into
three blocks A (2 weeks), B (4 weeks) and C (4 weeks).
During block A, the focus involves learning the exercises
and ensuring quality of the performance. During block B,
the level of difficulty of the exercises increases and cogni-
tive as well as motoric dual task exercises are introduced,
1 week at a time. During block C, exercises from all four
balance components are combined in order to increase
the complexity of training and participants are required to
switch between cognitive and motoric dual task exercises
during the same training session.
Adaptation of the HiBalance program to clinical settings
Adaptation of the HiBalance program was a measure
taken in the preparation phase to ensure its applicability
in the clinical context. An overview of these adaptations
is outlined in Table 1. The adaptation process occurred
during a series of peer-group meetings between the re-
search team, clinical trainers who had previously partici-
pated in the RCT as well as future clinical trainers.
Reducing the dose of the group training sessions from
30 to 20 hours was motivated primarily by current regu-
lations for rehabilitation funding in the Swedish national
healthcare system. Development and adaptation of the
home training program was based on trainer and
participant perceptions of the exercises, gathered during
the pilot study using questionnaires (participants) and
focus group interviews (trainers). Lab-based and time
consuming outcomes assessments employed during the
efficacy trial were substituted with more clinically feas-
ible assessments. A pilot study (data not published) was
then performed at two clinic settings in order to test the
feasibility of these adaptations. The objective of the pilot
study was to test the main uncertainties identified in the
development work prior to the effectiveness-
implementation study [21].
All physical therapist trainers will participate in 2 x
3 h sessions where they will receive theoretical and prac-
tical training in the HiBalance program as well as infor-
mation regarding the project design and goals. Project
materials will be provided covering all aspects of recruit-
ment, training and measurement and regular support
will be achieved with the research team though contact
by mail, telephone and meetings.
The following section outlines the study setting, and
for each study aim, participants, data collection proce-
dures, and analysis plans are described.
Study setting
The study will be conducted in 4–6 rehabilitation clinics
ranging in nature from primary care geriatric clinics to
out-patient clinics specializing in neurological physio-
therapy rehabilitation in Stockholm, Sweden. In Sweden
patients can receive out-patient physiotherapy treatment
without doctor/specialist referral and number of treat-
ments is decided upon on an individual basis. Health
care treatment cost is tax-funded and clinics receive
funding reimbursements for an average of eight treat-
ment sessions/patient during 1 year. Cost to the patient
is also regulated whereby in a 1 year period, individual
sessions cost an equivalent of 23 US dollars up to ceiling
of approx. 120 dollars, from which point onwards re-
habilitation treatment is free of charge during the
remaining year.
Study phases
When describing the varying phases of this study (Fig. 1)
we use taxonomy from Aaron’s conceptual model for
the dynamic adaptation process [27]. According to this
model, the implementation process can be divided into
four phases; exploration; adoption/preparation; imple-
mentation and sustainment. In Fig. 1 we describe the
first three of these stages of Aaron’s model and label the
third or ‘implementation’ stage as the ‘Outcome/Process
Evaluation’ as it applies to the current study. We deem
that the current study will be followed by post evalu-
ation scale-up where implementation will be tested on a
wider scale, before the sustainment stage of the HiBa-
lance program is actual. In the preparation phase for this
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study (Fig. 1) we will also, using a web-questionnaire, as-
sess the needs and resources of registered physical thera-
pists in Sweden in relation to their work with people
with PD. The web questionnaire will be sent to all phys-
ical therapists registered in the neurology, geriatrics and
out-patient care sections of the national organization in
Sweden. This information will then be used at the later
stage to inform wider-scale implementation.
Outcome evaluation of the intervention (Aim I)
The primary and secondary outcome measures of the
intervention will be assessed using a non-randomized
controlled clinical trial design. Eligible participants will
be consecutively included to the training groups, which
mirrors the standard approach in physical therapy re-
habilitation, and participants will be recruited both in-
ternally from within the clinics and in response to
advertisement in local newspapers.
Study participants
Inclusion criteria for the trial are outlined in Table 1. A
broadening of the age criteria in the current trial will
enable community-dwelling people at mild-moderate
stages of PD of all ages to be eligible for inclusion.
Power analyses will determine sample-size using data
from the Pilot study performed in the fall of 2015 as well
as the previous HiBalance RCT. Control participants will
be recruited and tested in a similar manner as those in-
volved in the intervention group. Control subjects will
be encouraged to continue their usual daily activities
during the 10-week period between measurements and
will not be advised against participating in other training
interventions.
Data collection
The testing procedure is also designed to reflect that
which occurs in real-life clinical practice and partici-
pants will be tested by physical therapists at baseline
(pre-training) and at 10-weeks (post training). Data col-
lection will occur at the respective clinics and be com-
prised of both clinical performance tests as well at self-
reported questionnaires. All participants will be tested
during the on-phase of their medication and testing will
Table 1 HiBalance program design differences between the efficacy and effectiveness-implementation stages
Program feature HiBalance-RCT (Efficacy phase) HiBalance-clinical setting (Effectiveness/Implementation phase)
Inclusion criteria Idiopathic Parkinson’s disease Idiopathic Parkinson’s disease
Hoehn & Yahr score of 2 or 3 Hoehn & Yahr score of 2 or 3
Able to walk independently indoors without an aid Able to walk independently indoors without an aid
Mini-Mental State examination score > 24 points Cognitively capable of following instructions in a group setting
Age ≥60 years All Ages
Core
components
Individually adapted, highly challenging and progressive
balance training in 3 blocks with progressively integrated
dual-task training
Individually adapted, highly challenging and progressive balance
training in 3 blocks with progressively integrated dual-
task training
Dose 30 h of group training
(3 x 1 h sessions/week x 10 weeks)
20 h of group training (2 x 1 h sessions/week x 10 weeks) 10 h
home exercise program (1 h/week x 10 weeks)
Providers Physical therapist PhD students (site responsible) and
clinicians
Physical therapist clinicians





Mini-BESTest score Mini-BESTest score
Modified figure of eight test
Physical activity
level






(A measure of concerns about falling)
Activities-specific balance confidence scale (ABC scale)
(A measure of balance confidence)
Activities of daily
living









Walking impact scale (Walk 12G)
Non-randomized controlled design
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be scheduled to occur at the same time on both test
occasions.
Outcome measures
Both performance-based and self-reported outcome
measures will assess the effectiveness of the intervention
(Table 1). The primary outcome measure is balance per-
formance which will be assessed using the 14-item Mini
Balance Evaluation Systems test (Mini-BESTest) [28]. This
test assesses four components of balance control; anticipa-
tory postural adjustments, postural responses, sensory
orientation, and stability in gait which are directly targeted
in the HiBalance program. Secondary outcomes will in-
clude gait velocity (measured by the 10-meter Walking
Test); functional mobility (measured by Timed Up and
Go test [29]); physical activity level (measured as steps per
day using a waist-worn accelerometer (Actigraph GT3X+,
Pensacola, FL, USA). In addition to performance-based
outcome measures, patient-reported outcomes will be
used. Balance confidence will be measured using the
Swedish version of the Activities-specific balance confi-
dence (ABC) scale [30]. This scale requires respondents to
rate their confidence to maintain balance during 16 differ-
ent real-life situations. The ABC scale substitutes the FES
(I) scale used in previous evaluations of HiBalance [17] as
this scale poses questions concerning a wider range of
potentially difficult and outdoor activities and is consid-
ered more suitable to detect changes in moderate to
highly functioning adults [31]. Self-rated health will be
measured using the EurQol’s EQ- 5D [32]. The EQ-5D-
3 L is a standardized non-disease-specific instrument for
describing health-related quality of life, and is a measure
already in use within rehabilitation in Sweden. When
using this instrument, respondents are required to rate
their health status in relation to 5 dimensions; mobility,
self-care, usual activities, pain/discomfort and anxiety/de-
pression. Subjective walking ability will be assessed using
the Swedish version of the Walking impact scale (walk
12G) [33], a 12-item generic patient-reported rating scale
measuring walking difficulty in everyday life as experi-
enced during the previous 2 weeks.
Data analysis
Sample size calculation was based on the results from
the pilot study (unpublished data) and calculated in rela-
tion to the primary outcome of balance control. In order
to attain 80% power with a two-sided alpha level of 5%,
the number of subjects required per group and the hy-
pothesized effect size (of 1 point according to the Mini-
BESTest) was 37. With an expected drop out rate of
15% during the course of the trial, this calculation will
require the inclusion of approximately 45 participants in
each group. The distribution of variables which can be
thought to confound study outcomes will be compared
at baseline between the control and intervention groups
using the Student t test, Mann-Whitney or Chi-squared
test, where appropriate. Where differences between
groups are found we plan to adjust for covariates which
Fig. 1 Overview of study phases for the HiBalance effectiveness-implementation trial
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are known to affect outcomes in PD. Where data is seen
to be of skewed distribution, logarithmic transformations
or non-parametric statistics will be used to assess the
effectiveness of the intervention. Repeated measures
analysis of variance test or mixed models, where appro-
priate, will test for interaction effects between the inter-
vention and control groups, post-hoc tests will be used
when significant interactions are found. All analysis will
be performed using the intention-to-treat principle and
95% confidence intervals will be calculated throughout.
Process evaluation of the implementation (Aim II)
In order to make an accurate interpretation of the out-
comes outlined above it is essential to understand the
quality and quantity of the intervention that was actually
delivered. For this reason, we will conduct a process
evaluation of the implementation of the effectiveness
study.
Research question relating to aim II
To what extent was the HiBalance program delivered as
intended and how was the delivery conducted?
The process evaluation will be guided by the UK med-
ical research council’s recommendations for planning
and conducting process evaluation of complex interven-
tions [21]. Process evaluations involve critically observ-
ing the work of the clinicians who are providing the
training intervention [21]. Participants involved in this
part of the study will therefore also include physical
therapist trainers at the respective clinical sites. Due to
the small numbers in individual clinics we will lack the
power to statistically assess site-based factors that influ-
ence implementation outcomes. We will therefore use a
mixed methods approach when evaluating the imple-
mentation process. This will be performed by data col-
lection from trainers, patients and professionals in the
field using interviews, questionnaires, analysis of patient
training diaries as well as physical therapist planning
protocols. We will, in accordance with the current im-
plementation literature, adopt measures to support the
implementation process by; adapting the HiBalance pro-
gram to the clinical context; engaging in shared-decision
making with project clinician trainers; increasing trainer
skills and by providing ongoing administrative and tech-
nical support [19].
Assessment of process outcomes
In order to fulfill the aims of the process evaluation
which are to examine the quality and quantity of what
was delivered it is necessary to assess outcomes such as
the fidelity and dose of the program as it was delivered,
as well as describe the recruitment process and reach of
the intervention (Table 2) [21].
Fidelity is defined as the degree to which the interven-
tion is implemented as prescribed or intended by the
program developers [34]. We aim to perform a fidelity
assessment of the implementation process by monitoring
the delivery of the core components of the HiBalance
program, as it was designed. Adherence to these core
components as well as the week-by-week structure of
the sessions will be quantitatively assessed through col-
lection and analysis of the planning materials used by
trainers to plan the group training sessions (Additional
file 1). Trainers at each clinic will be advised to dedicate
approximately 20 min to planning training sessions, in-
spired by program materials, and to document training
protocols following each session. Program features such
as the warm-up phase of the training sessions, on the
other hand, can be altered to achieve a better fit to spe-
cific clinics [19]. Fidelity will also be assessed qualita-
tively using open ended questions during focus-group
interviews where trainers will be allowed describe this
feature in their own words.
Dose: Both the dose of group training sessions deliv-
ered at the clinical sites, and the dose received by pa-
tients will be assessed. Dose received involves rate of
participation in both group and home training sessions
by participants. This data will be quantitatively assessed
using attendance protocol as well as home training
diaries.
Recruitment: the process of recruitment will be de-
scribed quantitatively for the various clinics and trainers
perceptions of recruitment will be qualitatively explored
during the focus group interviews.
Reach refers to the extent to which the target audi-
ence comes into contact with the intervention [20]. We
plan to describe to which extent those included in the
study are representative of the target population of
people with PD.
Assessing barriers and facilitators to implementation (Aim III)
In addition to evaluating ‘how’ and ‘what’ was imple-
mented by means of the process evaluation we will col-
lect data concerning potential barriers and facilitators to
the implementing the HiBalance program.
Research question relating to aim III
What are the potential barriers and facilitators to imple-
mentation of the HiBalance training program in out-
patient clinical settings?
Determinant framework
The Consolidated Framework for Implementation Re-
search (CFIR) will be used in the current study to guide
the investigation of potential barriers and facilitators of
the implementation process [35]. CFIR can be catego-
rized as a determinant framework, in that it can be used
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to identify determinants (i.e. barriers and facilitators) at
different levels (from the user to the program provider,
to the organizational level) that can be thought to influ-
ence the implementation process [36]. CFIR provides a
menu of constructs which are operationally defined and
stem from various disciplines such as psychology and
sociology [35]. We will choose constructs which we
hypothesize to specifically impact the implementation of
the HiBalance program from the following main
domains defined by CFIR; Intervention characteristics;
Inner setting; Outer setting and Characteristics of indi-
viduals. Table 2 provides an overview of the process out-
comes as well as the subdomains of the CFIR constructs
outlines above, which will guide data collection of the
process evaluation and in the assessment of barriers and
facilitators to implementation. However, we also ac-
knowledge such frameworks do not conceptualize the
role of unexpected events [37] and we aim therefore for
flexibility in the data collection to allow for emergent
factors concerning barriers and facilitators to be ex-
plored during the qualitative interview process [21].
Data collection
Data concerning aims II and III of the study will be col-
lected using a mixed method approach. Focus group in-
terviews will be performed with 3–6 physical therapists
at the various clinical sites as a means to explore the
process outcomes/barriers and facilitators outlined in
Table 2. We will follow guidelines published by CFIR
when developing the interview guide (http://
cfirguide.org/tools.html). Additional file 2 demonstrates
how interview questions are linked to CFIR constructs.
Interviews will aim to gather detailed information re-
garding trainer experiences and perceptions throughout
the evaluation period, in both the early and late stages of
the process. Additionally, structured questionnaires will
be used to capture aspects of patient experiences of the
program upon completion of the 10-week training
(Additional file 3).
Data analysis
Interviews transcripts will be systematically analyzed
using thematic qualitative content analysis. This method
is systematic, replicable and valid method in the analysis
of text data [38]. During data analysis the research team
will strive for an inductive approach to category develop-
ment, by allowing categories to emerge from the data as
opposed to driving category development by precon-
ceived theory. The analysis will be performed systematic-
ally in steps [39], involved research group debriefing
sessions which allow for researcher triangulation and en-
sure validity of the analysis process. Questionnaires and
planning protocols will be analyzed primarily using de-
scriptive statistics.
Discussion
If evidence-based training programs are to benefit those
with progressive neurological diseases, such as PD, the
findings from RCT’s must be translated to and tested in
everyday clinical settings. Additionally, there are a
Table 2 Overview of the process evaluation involving process outcomes and barriers and facilitators, targeted groups and data
collection methods
Process outcomesa Targeted groups Method of data collection
Fidelity Patient training diaries/
attendance
Physical therapist trainers sessions plans
Assessment of group training
protocols
Focus group interviews




Assessment of group training
protocols
Assessment of attendance at
group training/home training
protocols
Recruitment Physical therapist trainers Study logs and focus group
interviews
Reach Participants with PD Study logs
Barriers and facilitatorsb Targeted groups Method of data collection
Knowledge and beliefs about the program
Relative advantage of the program
Need for adaptability of the program
Self-efficacy to train patients according to the programs core
components
Perceived complexity/difficulty of implementing the program in everyday
practice
Physical therapist trainers Focus group interviews
Patients need and resources
Knowledge and beliefs about the balance program
Perceived complexity of performing the training
Participants with PD Structured questionnaire
aGuided UK Medical research council guidelines. bGuided by constructs defined by Consolidated Framework for Implementation Research
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scarcity of studies which clearly report the underlying
principles upon which such exercise programs are based
[40]. The HiBalance program described in the current
protocol has, on the other hand, been based on specific
underlying theoretical principles and been shown effect-
ive in an RCT [17]. For these reasons this program is
suitable for testing in an effectiveness study with the aim
of further implementation on a wider scale. We find to
date, no previously published trials which have tested
the effectiveness of training interventions in PD while
simultaneously evaluating the way in which the program
was implemented.
By using a hybrid design we intend to fill gaps in the
current knowledge concerning not only what to imple-
ment but also how to implement evidence-based balance
training for mild to moderate PD in clinical practice.
This study will therefore determine whether the adapted
HiBalance program is effective at improving balance
control, gait and physical activity level when provided in
standard physiotherapy practice. Our results will also in-
dicate whether implementation of the program is feas-
ible on a wider scale in the Swedish context and what
potential barriers and facilitators to this process may be.
In this study protocol we use a theoretical approach to
outline the core elements of the implementation process.
We also hypothesize that results from our study will be
highly relevant for those working within the field of
neurological rehabilitation when considering ways in
which to translate research findings into routine clinical
care. Use of predefined constructs regarding the planned
process evaluation also strengthens our design by enab-
ling the easy comparison of our results with those of
other studies concerning the implementation of health-
care interventions.
There will also be possible limitations to the proposed
study. Firstly, this intervention does not consist of a
fixed program of balance exercises, but relies on trainers’
adherence to the basic exercise principles in order to
plan and adapt training sessions. While this feature al-
lows exercises to be adapted and progressed at the indi-
vidual level, it may be difficult to fully evaluate program
fidelity. Extra efforts will therefore need to be made to
evaluate the level of fidelity to the theoretical principles
of the program throughout the implementation process.
Secondly, randomization of participants into treatment
and control groups was not considered feasible as the
program is provided at the clinical sites as a part of
standard physiotherapy treatment. Although consecutive
inclusion of participants mirrors standard practice and
therefore benefits external validity, a non-randomized
design limits our ability to rule out the effects of selec-
tion bias between the control and intervention groups.
Thirdly, in current physiotherapy treatment of people
with PD in Sweden, there is no uniform standard care
with which to compare the testing of this intervention.
This may hamper the extent to which a standardized
control group can be recruited.
This study represents a unique and structured ap-
proach to investigating the ways in which a rehabilita-
tion intervention with proven efficacy responds to
testing and implementation in real life clinical settings.
Our study design should benefit people with progressive
neurological conditions such as PD by providing valu-
able information which can speed up the process of
translating research findings to routine health care. We
hypothesize that study findings will produce highly ap-
plicable results not only for those in the field of PD, but
to clinicians on a wider scale who are planning to trans-
late research findings from training programs with
proven effectiveness to the patients who need them.
Trial status
At the time of manuscript submission the trial is in an
ongoing phase of recruitment and data collection at the
various clinical sites.
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